Status:

NOT_YET_RECRUITING

Evaluation of the Dialytic Clearance of the Combination of Peracillin and Tazobactam

Lead Sponsor:

University Hospital, Rouen

Conditions:

Sepsis

Severe Bacterial Infections

Eligibility:

All Genders

18+ years

Brief Summary

Severe bacterial infections, often responsible for sepsis and septic shock, are a major challenge in critical care: approximately 50% of patients are affected, with a mortality rate of up to 40%. Thei...

Detailed Description

Pip-taz is administered intravenously due to non-absorption via the oral route. It is weakly bound to plasma proteins (21%), inducing good clearance of extrarenal clearance (fraction extracted in 4 ho...

Eligibility Criteria

Inclusion

  • Adult patient over 18 years of age;
  • Patient admitted to intensive care with a prescription for cREV (CVVH (pre- or post-dilution (convection)), CVVHD (diffusion), CVVHDF);
  • Diagnosed or suspected infection sensitive to the piperacillin-tazobactam combination administered by continuous infusion as part of the patient's standard care;
  • Concomitant prescription of piperacillin-tazobactam and cREV;
  • Patient affiliated with a social security scheme;
  • Adult who has read and understood the information letter and has not expressed non-opposition. Due to the potential life-threatening emergency, if the patient is unable to express their non-opposition, the consent of a trusted person or, where applicable, relatives will be sought.

Exclusion

  • Documented or suspected allergy to penicillins;
  • Opposition from the patient or trusted person;
  • Pregnant, childbirth, or breastfeeding woman;
  • Minor patient;
  • Person deprived of liberty by an administrative or judicial decision;
  • Person placed under judicial protection, guardianship, or curatorship.

Key Trial Info

Start Date :

October 1 2025

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

April 1 2028

Estimated Enrollment :

24 Patients enrolled

Trial Details

Trial ID

NCT07167524

Start Date

October 1 2025

End Date

April 1 2028

Last Update

September 11 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

University Rouen Hospital

Rouen, France, 76031